Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wales addresses cancer diagnostics R&D (research and development) needs

This article was originally published in Clinica

Executive Summary

Cancer diagnostics is one of the top priorities of the Wales Cancer Institute (WCI), which was officially launched last week. This "virtual institute" will help to co-ordinate the research of scientists and clinicians - notably in Cardiff, Swansea and Bangor - and will have a role in attracting greater investment for cancer R&D in the principality. A key element of this network will be the Institute of Life Sciences (ILS) in Swansea, which opened last month (see Clinica No 1140, p 7).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054215

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel